´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦28Â÷ Ãá°èÇмú´ëȸ ¹× ÃÑȸ(1ÀÏÂ÷) : 2019-05-17±³À°ÀÏÀÚ : 2019-05-17
±³À°Àå¼Ò : ÇÏÀÌ¿ø±×·£µåÈ£ÅÚ ÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ :
Á¦28Â÷ Ãá°èÇмú´ëȸ ¹× ÃÑȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ¿µ»óÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ
´ã´çÀÚ : ÁÖÇýÁ¤
¿¬¶ôó : 02-465-9070
À̸ÞÀÏ :
office@intervention.or.kr ±³À°Á¾·ù : ¿µ»óÀÇÇаúÀÇ»çÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥,
Âü¼®¿¹»óÀοø : 350¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
°¿øµµ±³À°½Ã°£ : 4 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í »çÀüµî·Ï:Á¤È¸¿ø 50000¿ø, Àü¹®ÀÇ 100000¿ø, °øº¸.Àü°øÀÇ 30000¿ø, ÁØȸ¿ø 50000¿ø/ÇöÀåµî·Ï: Á¤È¸¿ø 70000¿ø, Àü¹®ÀÇ 120000¿ø, °øº¸.Àü°øÀÇ 50000¿ø, ÁØȸ¿ø 70000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:00~13:10 Iatrogenic Arterioportal Fistula Caused by Radiofrequency Ablation of Hepatocellular Carcinoma: Clinical Courses and Treatment Outcomes ÃÖÁø¿ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:10~13:20 Radioembolization of hepatocellular carcinoma in a large single center cohort: response and survival evaluation ±è°æ¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:20~13:30 Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by conventional transcatheter arterial chemoembolization: threshold value of intratumoral Lipiodol accumulation predicting tumor necrosis ¹ÚÂù(¿ï»êÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:30~13:40 Spectral CT-based iodized oil quantification to develop a tumor response prediction model for chemoembolization of hepatocellular carcinoma ÃÖ¿ø¼®(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:40~13:50 HepaSphere (30–60 ¥ìm) Transarterial Chemoembolization vs. Conventional Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score Matched Analysis of Early Clinical Outcomes ±èÁø¿µ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:50~14:00 AORTOCELIAC ANGLE IN PERCUTANEOUS IMPLANTATION OF PORT-CATHETER SYSTEM FOR HEPATIC ARTERIAL INFUSION CHEMOTHERAPY: COMPARISON OF SUBCLAVIAN VS FEMORAL APPROACH ±è¼öÈ£(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:00~14:10 BTK angioplasty using subintimal rendezvous via dorsalis pedis artery °Ã¤ÈÆ(À»ÁöÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:10~14:20 RFA of oligometastasis of lymph nodes and peritoneum in the abdominal and pelvic cavity from non-hepatocellular carcinoma Á¤µ¿Áø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:20~14:30 Retrograde Thoracic Duct Embolization À±Á¦È«(°æÈñÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:30~14:40 Interventional Treatment of uncontrolled urine leakage: 2 cases ¼Å¼®(°í´ëÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:40~14:50 Transrenal hemodialysis catheter insertion ½ÅÁöÈÆ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:50~15:00 Endovascular Treatment of Traumatic Suprahepatic IVC Rupture ±èÇü¿í(Àü³²ÀÇ´ë)
Åä·Ð 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 15:00~15:10 Discussion Á¶¿µÁØ, ÀÓ³²¿, Çã¼¼¹ü(ÀÎÁ¦ÀÇ´ë, Àü³²ÀÇ´ë, ¼¿ïÀÇ´ë)
ÈÞ½Ä 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 15:10~15:30 Coffee break ()
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 15:30~15:45 Pediatric Interventional Radiology: General Considerations Lisa Kang()
Åä·Ð 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 15:45~16:00 Discussion °í±â¿µ, ±è¹Î¿í, Àü¿õ¹è(¿ï»êÀÇ´ë, ÀÌÈÀÇ´ë, ºÎ»êÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 16:00~16:15 Hepatobiliary surgery Àüâȣ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 16:15~16:30 Esophageal and lung surgery Çöµ¿È£(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 16:30~16:45 Gastrectomy Çѱââ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 16:45~17:00 Urologic surgery ÀÌ¿õÈñ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 17:00~17:10 What¡¯s new-Cook ÀÌ¿ì¶÷(Cook)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 17:10~17:20 What¡¯s new-Boston Scientific ½ÉÀçÇö(Boston Scientific)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 17:20~17:30 What¡¯s new-Phillips À̼ºÈñ(Phillips)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 17:30~17:40 What¡¯s new-¢ß¿¡½º¿ÍÀ̸޵ðÄɾî À̹μ®(¢ß¿¡½º¿ÍÀ̸޵ðÄɾî)
±³À°½Ã°£ 05-17 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 17:40~17:50 What¡¯s new-Teleflex Korea ±è½ÅÈ£(Teleflex Korea)